GPC3 and hepatocellular carcinoma: As shown in Fig. 5c, d, treatment with CD8+T cells induced by GPC3 or PEG10 long peptide showed a significant therapeutic effect against HCC compared to that in the control (all P < 0.05 or 0.01).